International Patent: PROTAC COMPOUND FOR TARGETED DEGRADATION OF CDK2, PREPARATION METHOD THEREFOR AND USE THEREOF

GENEVA, July 2 -- XIMEILAI (TIANJIN) BIOMEDICAL TECHNOLOGY CO., LTD. filed a patent application (CN2026/074514) for “PROTAC COMPOUND FOR TARGETED DEGRADATION OF CDK2, PREPARATION METHOD THEREFOR AND USE THEREOF”. With publication no. WO/2026/130584, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 487/04

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....